# Osler Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/osler-diagnostics

- Industry: Medical Devices & Equipment
- Headquarters: Oxford, UK
- Website: www.oslerdiagnostics.com
- Total disclosed funding: $130M
- Latest round: Series C (Nov 8, 2022)
- Investors on record: 6

## About

Founded in 2017 and based in Oxford, UK, Osler Diagnostics Limited operates as a manufacturer of medical equipment where users can access diagnostics anytime and anywhere. Connor Campbell is the co-founder and CEO of the company, which employs 100 employees as of 2022. In November 2022, Osler Diagnostics Limited raised USD 85 million in Series C funding from M&G Investments, including Braavos Investment Advisers, Lansdowne Partners, and Oxford Sciences Enterprises.

The company offers Osler Origin, a portable lab that unifies several existing technologies into a single device that can handle several key analyte classes and delivers lab-quality diagnostics to anyone, anywhere, at any time. The firm's device is powered by Osler's lab-in-your-hand technology, which combines electrochemical biosensing, microfluidic sample preparation, and Osler HemaTap sample addition.

The organization plans to use the November 2022 funding to advance its Osler Origin product through regulatory activities and onto the market.

## Funding rounds

- Series C, Nov 8, 2022, $84M — Lansdowne Partners, M&G, Oxford Sciences Enterprises, Braavos Investment Advisers
- Series B, Nov 20, 2020, $46M — Lansdowne Partners, Oxford Sciences Enterprises, Puhua Capital, Freston Ventures

## Investors

- Lansdowne Partners (https://capitalatlas.ai/funds/lansdowne-partners) — Series B, Series C
- Oxford Sciences Enterprises (https://capitalatlas.ai/funds/oxford-sciences-enterprises) — Series B, Series C
- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Series B
- Freston Ventures (https://capitalatlas.ai/funds/freston-ventures) — Series B
- M&G (https://capitalatlas.ai/funds/m-g) — Series C
- Braavos Investment Advisers (https://capitalatlas.ai/funds/braavos-investment-advisers) — Series C